Affiliation:
1. St. John Hospital and Medical Center, Detroit, Michigan
Abstract
ABSTRACT
This study assessed the
in vitro
activities of ceftaroline and five comparator agents against a collection of
Staphylococcus aureus
isolates. Ceftaroline demonstrated potent activity against community-associated methicillin-resistant
S. aureus
(CA-MRSA) isolates and showed bactericidal activity against vancomycin-intermediate
S. aureus
(VISA), vancomycin-resistant
S. aureus
(VRSA), heteroresistant VISA (hVISA), and daptomycin-nonsusceptible
S. aureus
(DNSSA) isolates. Ceftaroline may represent a bactericidal treatment option for infections caused by these pathogens.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference24 articles.
1. In Vitro Antimicrobial Activity of a New Cephalosporin, Ceftaroline, and Determination of Quality Control Ranges for MIC Testing
2. Centers for Disease Control and Prevention. 2005. Community-associated MRSA information for clinicians. Released 3 February 2005. http://www.cdc.gov/ncidod/dhqp/ar_MRSA_ca_clinicians.html#6
. Accessed 16 June 2009.
3. Charles, P. G., P. B. Ward, P. D. Johnson, B. P. Howden, and M. L. Grayson. 2004. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin. Infect. Dis.38:448-451.
4. Performance standards for antimicrobial susceptibility testing 18th informational supplement M100-S18. 2008
5. Methods for determining bactericidal activity of antimicrobial agents; approved guidelines. 1999
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献